Cure My Disease

Don't miss your cure!

 Log in / Sign up

First human trial of ENC0653 ointment begins safety testing

NCT ID NCT07684196

Recruiting now Knowledge-focused Sponsor: EnnovaBio Source: ClinicalTrials.gov ↗

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests whether ENC0653 ointment is safe when applied to the skin of healthy adults. Researchers will give single or multiple doses to small groups and monitor for side effects. The goal is to understand how the body processes the ointment and whether it causes any harm. This is a first-in-human trial, so no treatment benefits are expected.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ENC0653 ointment
What could go wrong
This is an early Phase 1 safety study in healthy volunteers, so it does not test whether the ointment treats any disease. The results may not predict effectiveness in patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY

Contacts and locations

Locations

  • Shanghai Xuhui Central Hospital

    RECRUITING

    Shanghai, Xuhui District, 200237, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.